Organisation paid for research Program year 2022 Source: CMS Open Payments

Clinical Partners

Neither a doctor nor a teaching hospital

Research payments

$106,705

53 payments

Through program year 2022, Clinical Partners is reported as receiving $106,705 in research payments, across 53 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$5,423	2
2021	Research	$29,881	5
2020	Research	$52,974	14
2019	Research	$18,427	32

Breakdown

Who paid Research payments · program years 2019–2022

Boehringer Ingelheim Pharmaceuticals, Inc. $83,259 14 payments
Boehringer Ingelheim International GmbH $9,513 13 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $8,913 25 payments
Novartis Pharmaceuticals Corporation $5,019 1 payment

Studies the money was for Research payments · program years 2019–2022

BI 730357 PoCC and dose ranging in Psoriasis $36,954 5 payments
BI 730357 Psoriasis Long Term Extension $32,154 6 payments
Dose finding Trial in PPP Phase II $14,151 3 payments
BI 730357 PoCC and dose-ranging in Psoriasis $9,607 30 payments
A Multicenter Double Blind Randomized Withdrawal Extension Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate Long Term Efficacy Safety and Tolerability Up to 2 Years in Subjects With Moderate to Severe Chronic Plaque Type Psoriasis Co $5,019 1 payment
Dose finding Trial in PPP (Phase II) $4,398 3 payments
Comparative study in Psoriasis $3,223 1 payment
BI 730357 - Psoriasis Long-Term Extension $1,199 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.